Eli Lilly's $40M AI Drug Bet: Revolutionizing Injectables | OWITH Daily

Good morning from OWITH.ai, the podcast that gives you only what's important to hear in the AI and tech world. Eli Lilly has made a significant investment of $40 million in Absci, a generative AI drug company, as part of a larger $100 million stock offering. This move aims to advance the development of ABS-201, an injectable antibody targeting the prolactin receptor, linked to hair growth and reproductive health. ABS-201 seeks to address conditions such as androgenetic alopecia and endometriosis, which currently lack approved injectable antibody treatments. Eli Lilly's investment not only provides strategic proximity to Absci's operations but also aligns with both companies' aspirations to revolutionize drug delivery through direct-to-consumer models. The injectable market is expected to represent a $650 billion opportunity by 2026, with GLP-1 drugs projected to reach up to $200 billion by 2030. However, oral GLP-1 versions from companies like Lilly and Novo Nordisk present challenges for injectables unless biologically necessary. Absci contends that proteins in ABS-201 are destroyed in the stomach, making injectable delivery essential. The potential of AI-driven drug development is further highlighted by substantial investments in the sector, with companies like Isomorphic Labs, Earendil Labs, and Xaira Therapeutics securing significant funding. Despite uncertainties surrounding ABS-201's efficacy in humans, Eli Lilly's backing underscores its commitment to advancing AI-designed drugs and injectables. The broader convergence of AI technology and pharmaceuticals signals a transformative period for drug development and healthcare innovation. Looking ahead to July 2026, reports suggest that Microsoft may announce significant layoffs as a cost management strategy due to increasing AI expenditures. The potential job cuts could impact various divisions such as Xbox and sales teams, affecting less than 2.5% of Microsoft's workforce. Previous measures included offering buyouts to about 7% of its U.S. workforce and conducting layoffs last year to control spending amidst growing AI investments. Despite these efforts, Microsoft shares have experienced a decline this year. In legal developments, TikTok has settled a lawsuit alleging harm to a minor's mental health due to social media addiction. The case involved companies like Google's YouTube and Meta's Instagram, with trials continuing for the latter two. This lawsuit is part of over 3,000 similar cases in California claiming that social media platforms are designed to be addictive. In recent legal news, the Supreme Court's ruling affirming birthright citizenship in the United States has been widely celebrated for its projected positive impact on the economy. Upholding the 14th Amendment right for children born on U.S. soil to claim citizenship regardless of their parents' immigration status could contribute substantially to economic growth over beneficiaries' lifetimes. This decision ties into broader discussions about the American Dream, with U.S. immigrants generally expressing more optimism than the native population. In the financial sector, a consortium led by major banks and tech companies has announced the launch of Open USD (OUSD), a new stablecoin pegged to the U.S. dollar. This initiative aims to reduce fees associated with minting and redeeming stablecoins while allowing partners to benefit from revenues on underlying reserves. In other tech news, Anthropic has introduced a new AI model named Claude Sonnet 5. OpenAI engineers have reportedly made progress in reducing inference costs, while Amazon has announced a new unit focused on helping companies deploy custom AI agents. Additional developments include Dell's AI-driven growth amidst profit margin concerns and generational skepticism about the American Dream among Gen Z and millennials. Over 140 businesses are launching a stablecoin to compete with Tether and Circle, while Revolut is implementing compulsory office attendance for new Gen Z employees with future flexibility promises. As always, these stories provide insights into ongoing changes across industries driven by financial strategies, legal challenges, and advancements in technology.Support the showThanks for listening! Follow us on Twitter, Instagram and Linkedin